DEVELOPMENT AND LICENSE AGREEMENTDevelopment and License Agreement • April 28th, 2006 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
INNEXUS CORPORATION, a company incorporated under the laws of Washington State and having an office at 3405 172nd Street, #196, Arlington (Seattle), Washington, U.S.A., 98223
EMPLOYMENT AGREEMENTEmployment Agreement • August 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
Cusil Venture Corporation, a body corporate, duly incorporated under the laws of the Province of British Columbia, and having an office at 1400 – 400 Burrard Street, Vancouver, British Columbia, V6C 3G2
This Agreement entered into on this 7Ul day of July, 2003 (the "Effective Date")Agreement • July 14th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
a company duly incorporated under the laws of the Province of British Columbia and having an office at 1400 ~ 400 Burrard Street, Vancouver, BC V6C 3G2
CONSULTING AGREEMENTConsulting Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
CUSIL VENTURE CORPORATION, a corporation incorporated under the laws of British Columbia and having an office at 1400-400 Burrard Street, Vancouver, B.C. V6C 3G2
CONSULTING AGREEMENTConsulting Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
This Agreement is made as of January 15, 2004 by and between Garth Likes and BC Company 672442 (Consultant) and InNexus Biotechnology Inc. (Company).
ASSENT TO ASSIGNMENT OF RIGHTSAssignment of Rights • April 28th, 2006 • Innexus Biotechnology Inc • Pharmaceutical preparations
This ASSENT TO ASSIGNMENT OF RIGHTS (hereinafter referred to as the "Agreement”) is entered into on this 3rd day of July, 2003, by and between BioKinetix Research, Incorporated (hereinafter referred to as "BIOK."), a corporation organized under the laws of the Province of Alberta, Canada, and whose principal business address is 1500 - 885 West Georgia Street, Vancouver, British Columbia V6C 3B8, and INNEXUS, Incorporated (hereinafter referred to as "INNEXUS"), a corporation organized under the laws of the State of Washington, USA.
THIS DEBT SETTLEMENT AGREEMENT made as of March 18, 2002. BETWEEN:Debt Settlement Agreement • August 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
EMPLOYMENT AGREEMENTEmployment Agreement • December 31st, 2008 • Innexus Biotechnology Inc • Pharmaceutical preparations • Arizona
This EMPLOYMENT AGREEMENT (“Agreement”) made and entered into as of the 17th day of March, 2008, by and between InNexus Biotechnology, Inc.(the “Company”), a Canadian corporation, and Jeff Morhet (the “Executive”);
ESCROW AGREEMENTEscrow Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
This Agreement is being entered into by the Parties under Exchange Policy 5.4 - Escrow, Vendor Consideration and Resale Restrictions (the Policy) in connection with a technology transfer transaction. The Issuer is a Tier 2 Issuer as described in Policy 2.1 - Minimum Listing Requirements.
CONSULTING AGREEMENTConsulting Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
WEST OAK CAPITAL GROUP, INC., a corporation incorporated under the laws of British Columbia and having an office at 1400-400 Burrard Street, Vancouver, B.C. V6C 3G2 (Telephone: (604) 689-1749; Fax: (604) 643-1789)
Cusil Venture Corporation Vancouver, B.C. V6C 3G2 Tel: (604) 689-1749 Fax: (604) 643-1789Innexus Biotechnology Inc • August 23rd, 2004 • Pharmaceutical preparations • British Columbia
EMPLOYMENT AGREEMENTEmployment Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • Arizona
EMPLOYMENT AGREEMENT made and entered into as of the 15th day of October,2006, by and between InNexus Biotechnology, Inc.(the "Company"), a Canadian corporation, and Wade F. Brooksby (the "Executive");
Sponsorship and Agency AgreementSponsorship and Agency Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
LOAN AGREEMENTLoan Agreement • August 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
WHEREAS The Borrower wishes to borrow and the Lender is willing to lend the sums set forth herein upon and subject to the terms set forth herein;
Research & Development AgreementDevelopment Agreement • July 14th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • Washington
INNEXUS BIOTECHNOLOGY INTERNATIONAL LIMITED a company incorporated under the laws of Barbados having an office Parker House, Wildey Business Park, Wildey Road, St. Michael, Barbados and its affiliate Companies, ( “InNexus”) on one hand,
EXCHANGE AGREEMENTExchange Agreement • August 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
GENERAL SECURITY AGREEMENTGeneral Security Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
InNexus Inc., a corporation duly incorporated under the laws of the State of Washington, having an office at #196, 3405- 172nd Street, Arlington (Seattle), Washington 98223
LICENSE AGREEMENTLicense Agreement • July 13th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
INNEXUS BIOTECHNOLOGY INTERNATIONAL LIMITED a company incorporated under the laws of Barbados having an office Parker House, Wildey Business Park, Wildey Road, St. Michael, Barbados and its affiliate Companies (“INNEXUS”),
THIS DEBT SETTLEMENT AGREEMENT made as of May 7, 2002. AMONG:Debt Settlement Agreement • August 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS INC.. a company duly incorporated pursuant to the laws of the State of Washington and having its offices at 3405 - 172nd Street NE, #196, Arlington, Washington, 98223 (Phone No. (425) 696-0068)
AMENDMENT AGREEMENTAmendment Agreement • July 14th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
CUSIL VENTURE CORPORATION, a corporation duly incorporated under the laws of the Province of British Columbia, having an office at 1400-400 Burrard Street, Vancouver, B.C., V6C 3G2;
SUB-LEASE AGREEMENTSub-Lease Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
THIS SUBLEASE AGREEMENT ("Sub-Lease") is made, entered into and executed this 1 t day of November, 2007, by and between InNexus Biotechnology, Inc. (hereinafter "Sub-Lessor") and Systems Medicine LLC, a wholly owned subsidiary of Cell Therapeutics, Inc. (hereinafter called "Sub-Lessee"). Sub-Lessor and Sub-Lessee contract and agree as follows:
Letter Agreement - Scientific Advisory Board InNexus April 17, 2007Letter Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
As we have discussed, I ask for you to serve as a member of InNexus' Scientific Advisory Board. I am delighted in your interest and below, I have detailed the terms of your service. As a member of the Scientific Advisory Board, I expect you to provide your best advice and recommendations regarding InNexus' antibody technology. providing a peer review function and giving me your best effort in this regard. The Scientific Advisory Board will not be directly responsible for research, publication of research results, participation in research studies, validation of scientific studies, or compilation of data or information. Rather, you serve to advise.
EXHIBIT “B” EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
, 2007 (the “Effective Date”), by and among InNexus Bioscience (Barbados) Inc., a company incorporated in Barbados (“Licensee”) and InNexus Biotechnology International Limited, a company incorporated in Barbados (“Licensor”).
AMENDING AGREEMENTAmending Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY INC., a company having an office located at 13208 East Shea Boulevard, Suite 1135, Scottsdale, Arizona 85259 (the "Company")
SECURITY AGREEMENTConfidential Treatment • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
Innexus Biotechnology Inc., a corporation incorporated under the laws of the Province of British Columbia, Canada having an office at Suite 2760-200 Granville Street, Vancouver, British Columbia
CONSULTING AGREEMENTConsulting Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY, INC, a corporation incorporated under the laws of placeStateBritish Columbia and having an office at addressStreet200 Granville Street, Suite 2760. placeCityVancouver, StateBC, country-regionCanada PostalCodeV6C 1S4
CONSULTING AGREEMENTConsulting Agreement • December 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY INC., a corporation incorporated under the laws of British Columbia and having an office at 1400-400 Burrard Street, Vancouver, B.C. V6C 3G2 (hereinafter called the "Company")
INNEXUS EVOGENIX MATERIAL TRANSFER AGREEMENTInnexus Evogenix Material Transfer Agreement • November 13th, 2006 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
This MATERIAL TRANSFER AGREEMENT (Agreement), is made effective as of August 1st, 2005 (Effective Date) and is entered into by and between InNexus Biotechnology Inc., a Canadian corporation having an address at 14th Floor, Commerce Place, 400 Burrard Street, Vancouver, BC, V6C 3G2, Canada (InNexus) and EvoGenix Ltd an Australian Corporation having an address at Level 2, 37 Bligh Street, Sydney NSW 2000 Australia, (EvoGenix) and subsequently both herein shall be referred to collectively as the “Parties”.
CONSULTING AGREEMENT THIS AGREEMENT dated as at June 8, 2007Consulting Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY INC., having its corporate offices at 200 Granville Street, Suite 2760, Vancouver, BC, Canada V6C 1S4 with principal management being based at 13208 East Shea Boulevard, Suite 200, Scottsdale, AZ 85259 (hereinafter called the "Company")
AGREEMENTAgreement • December 23rd, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
LETTER OF AGREEMENTLetter of Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • York
Section 2, Fees, The Company shall pay to IRO for its services hereunder a maintenance fee of S 7,250 per month for a: renewable term of 12 months beginning August 1, 2007,
SCIENCE RESEARCH SERVICE AGREEMENTScience Research Service Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • Arizona
Effective June 1, 2007, and continuing until revoked by one of the parties, this Science Research Service Agreement (the “Agreement”) between InNexus Bioscience (Barbados), Inc. (the “Company”) and InNexus Biotechnology Inc. (the “Service Provider”) (collectively, the “Parties”), provides as follows:
EXTENSION AGREEMENTExtension Agreement • May 28th, 2004 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
ROYALTY AGREEMENTConfidential Treatment • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
By way of a license agreement dated as of the date hereof (the “License Agreement”), Grantor acquired an irrevocable right and license to Exploit certain Licensed IP from its affiliate, InNexus International, the holder of the underlying Licensed Patents;
LETTER OF AGREEMENT Dated ; July. 24, 2007Letter of Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • York
..placeSnsection SnI. Services to be Rendered. The purpose of this letter is to set forth the terms and conditions on which The Investor Relations Croup, Inc. (IRG) agrees to provide InNexus Biotechnology Inc. (the "Company") a comprehensive public relations program, These services may include, but are not limited to: overall management of the public relations program; targeted mailings and phone calls to the media-at-large: assistance with compiling promotional materials; writing and editing news releases and other corporate materials; advice on packaging the Company story: writing pitch letters to and solicitation of the appropriate media and press; syndicated stories; and, daily update reports. For a comprehensive list, see Addendum "A".
